Tilmann Weber is Professor for Natural Products Genome Mining at the Novo Nordisk Foundation Center for Biosustainability of the Technical University of Denmark
His main research interest is focused on developing and using state-of-the-art metabolic engineering technologies to facilitate finding and engineering the next generation of natural product-based drugs and chemicals. In particular, his group is deciphering the molecular pathways and engineering the biosynthesis of natural products by combining genetic, biochemical and bioinformatics methods. He is a pioneer in developing software for the automated genome mining (CLUSEAN, antiSMASH, antiSMASH-DB) and analysis of secondary metabolite biosynthetic pathways. His group was able to firstly elucidate the biosynthetic pathways of the elfamycin family of antibiotics and is deeply involved in developing CRISPR-based metabolic engineering tools for actinomycetes.
Tilmann Weber is coordinator of the Challenge grant “Integration of Informatics and Metabolic Engineering for the Discovery of Novel Antibiotics (iimena)” funded by the Novo Nordisk Foundation.
Kemitorvet, bygning 220
2800 Kongens Lyngby
Denmark
